Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer

Human Pathology

Volumn 44, Issue 11, 2013, Pages 2549-2557

  Tchou, Julia ^a,b   Zhang, Paul J ^c   Bi, Yingtao ^d   Satija, Celine ^a   Marjumdar, Rajrupa ^d   Stephen, Tom L ^d   Lo, Albert ^d   Chen, Haiying ^a   Mies, Carolyn ^c   June, Carl H ^b,c   Conejo Garcia, Jose ^d   Puré, Ellen ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WISTAR INSTITUTE   (United States)

Author keywords

FAP expression; Human breast cancer; Tumor associated macrophages

Indexed keywords

CELL MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL ACTIVATION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MESENCHYME CELL; PROTEIN EXPRESSION; SINGLE CELL ANALYSIS; STROMA CELL; TISSUE SECTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

FAP EXPRESSION; HUMAN BREAST CANCER; TUMOR-ASSOCIATED MACROPHAGES;

ACTINS; ADULT; AGED; ANTIGENS, CD45; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MACROPHAGES; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; SERINE ENDOPEPTIDASES; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885577414     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.06.016     Document Type: Article

References (28)

1. D. Pardoll, and C. Drake Immunotherapy earns its spot in the ranks of cancer therapy J Exp Med 209 2012 201 209
2. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
3. H. Sugimoto, T.M. Mundel, M.W. Kieran, and R. Kalluri Identification of fibroblast heterogeneity in the tumor microenvironment Cancer Biol Ther 5 2006 1640 1646
4. W.J. Rettig, P. Garin-Chesa, and J.H. Healey Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin Cancer Res 53 1993 3327 3335
5. W.J. Rettig, S.L. Su, and S.R. Fortunato Fibroblast activation protein: purification, epitope mapping and induction by growth factors Int J Cancer 58 1994 385 392
6. M.T. Levy, G.W. McCaughan, and C.A. Abbott Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis Hepatology 29 1999 1768 1778
7. J.E. Park, M.C. Lenter, R.N. Zimmermann, P. Garin-Chesa, L.J. Old, and W.J. Rettig Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts J Biol Chem 274 1999 36505 36512
8. M. Loeffler, J.A. Kruger, A.G. Niethammer, and R.A. Reisfeld Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake J Clin Invest 116 2006 1955 1962
9. A.M. LeBeau, W.N. Brennen, S. Aggarwal, and S.R. Denmeade Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin Mol Cancer Ther 8 2009 1378 1386
10. A.M. Santos, J. Jung, N. Aziz, J.L. Kissil, and E. Pure Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice J Clin Invest 119 2009 3613 3625
11. Y. Wen, C.T. Wang, and T.T. Ma Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model Cancer Sci 101 2010 2325 2332
12. M. Kraman, P.J. Bambrough, and J.N. Arnold Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha Science 330 2010 827 830
13. N. Ariga, E. Sato, N. Ohuchi, H. Nagura, and H. Ohtani Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast Int J Cancer 95 2001 67 72
14. S. Adams, G.T. Miller, M.I. Jesson, T. Watanabe, B. Jones, and B.P. Wallner PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism Cancer Res 64 2004 5471 5480
15. R.D. Hofheinz, S.E. al-Batran, and F. Hartmann Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer Onkologie 26 2003 44 48
16. M. Mersmann, A. Schmidt, and J.F. Rippmann Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas Int J Cancer 92 2001 240 248
17. K. Narra, S.R. Mullins, and H.O. Lee Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer Cancer Biol Ther 6 2007 1691 1699
18. E. Tran, D. Chinnasamy, and Z. Yu Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia J Exp Med 210 2013 1125 1135
19. J. Tchou, L.C. Wang, and B. Selven Mesothelin, a novel immunotherapy target for triple negative breast cancer Breast Cancer Res Treat 133 2012 799 804
20. P. Garin-Chesa, L.J. Old, and W.J. Rettig Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers Proc Natl Acad Sci U S A 87 1990 7235 7239
21. S. Welt, C.R. Divgi, and A.M. Scott Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts J Clin Oncol 12 1994 1193 1203
22. J.R. Cubillos-Ruiz, D. Martinez, and U.K. Scarlett CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells Oncotarget 1 2010 329 338
23. A. Saadi, N.B. Shannon, and P. Lao-Sirieix Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers Proc Natl Acad Sci U S A 107 2010 2177 2182
24. J.D. Cheng, S.J. Cohen, and B. Stzempkowski-Brun Phase II pharmacodynamic study of the fibroblast activation protein inhibitor Val-boro-Pro in patients with metastatic colorectal cancer J Clin Oncol 24 2006 3594
25. M.L. Pineiro-Sanchez, L.A. Goldstein, and J. Dodt Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease J Biol Chem 272 1997 7595 7601
26. M. Jacob, L. Chang, and E. Pure Fibroblast activation protein in remodeling tissues Curr Mol Med 12 2012 1220 1243
27. R. Abe, S.C. Donnelly, T. Peng, R. Bucala, and C.N. Metz Peripheral blood fibrocytes: differentiation pathway and migration to wound sites J Immunol 166 2001 7556 7562
28. D. Pilling, T. Fan, D. Huang, B. Kaul, and R.H. Gomer Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts PLoS One 4 2009 e7475